TriStem has been granted permission to use the technology to treat a dozen patients with a bone marrow disorder called aplastic anaemia in an unnamed country, according to the magazine.

• “合作进行此次临床试验的当地政府部门要求公司就病人的国籍和身份保密。”公司补充说。